Williams Jones Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$91.9K	Hold	101,300	–	–	﹤0.01%	489
2025 Q1	$45.7K	Hold	101,300	–	–	﹤0.01%	483
2024 Q4	$50.9K	Hold	101,300	–	–	﹤0.01%	486
2024 Q3	$91.7K	Hold	101,300	–	–	﹤0.01%	518
2024 Q2	$101K	Hold	101,300	–	–	﹤0.01%	500
2024 Q1	$150K	Hold	101,300	–	–	﹤0.01%	512
2023 Q4	$110K	Hold	101,300	–	–	﹤0.01%	514
2023 Q3	$120K	Hold	101,300	–	–	﹤0.01%	510
2023 Q2	$143K	Hold	101,300	–	–	﹤0.01%	494
2023 Q1	$152K	Hold	101,300	–	–	﹤0.01%	521
2022 Q4	$119K	Hold	101,300	–	–	﹤0.01%	520
2022 Q3	$114K	Hold	101,300	–	–	﹤0.01%	530
2022 Q2	$160K	Hold	101,300	–	–	﹤0.01%	532
2022 Q1	$156K	Hold	101,300	–	–	﹤0.01%	495
2021 Q4	$248K	Buy	+101,300	New	+$248K	﹤0.01%	431
2021 Q2	–	Sell	-101,300	Closed	-$238K	–	510
2021 Q1	$238K	Hold	101,300	–	–	﹤0.01%	430
2020 Q4	$178K	Hold	101,300	–	–	﹤0.01%	441
2020 Q3	$95K	Hold	101,300	–	–	﹤0.01%	417
2020 Q2	$88K	Hold	101,300	–	–	﹤0.01%	397
2020 Q1	$84K	Hold	101,300	–	–	﹤0.01%	361
2019 Q4	$90K	Sell	101,300 -361	-0.4%	-$321	﹤0.01%	431
2019 Q3	$100K	Buy	+101,661	New	+$100K	﹤0.01%	413